Hanall Biopharma, Stock Price 25,150 KRW (-2.14%)... Bulletin Board 'Bustling'
At this time, posts about HanAll BioPharma are surging on portals and securities communities. Today, foreigners have net sold 129,678 shares of HanAll BioPharma, and institutions have net sold 40,000 shares, according to provisional data. HanAll BioPharma is known as an R&D-focused pharmaceutical and bio company.
As of 1:31 PM on the 15th, HanAll BioPharma's stock price is 25,150 KRW, down 2.14% from the previous day, with a trading volume of 834,534 shares, which is 52.91% of the 5-day average trading volume.
In addition to HanAll BioPharma, posts by investors are also surging for Korea & Company (000240), Netmarble Games (225570), and Camu E&C (013700).
Hot Picks Today
As Samsung Falters, Chinese DRAM Surges: CXMT Returns to Profit in Just One Year
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- Man in His 30s Dies After Assaulting Father and Falling from Yongin Apartment
- Samsung Union Member Sparks Controversy With Telegram Post: "Let's Push KOSPI Down to 5,000"
- "Why Make Things Like This?" Foreign Media Highlights Bizarre Phenomenon Spreading in Korea
※Source: AI Investment Assistant AI Lassiro
※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
